BioSpace News Archive

The European Commission selected rqmicro, a Swiss startup company, among more than 1,200 competitors. This financial support accelerates the development and market launch of a revolutionary solution for the rapid detection of pathogenic microorganisms.

Heska Corporation, a provider of advanced veterinary diagnostic and specialty products, announced that Steve Eyl, Heska’s EVP of Global Sales & Marketing, and Jon Aagaard, Director of Investor Relations, will be holding one-on-one meetings at CL King’s 16th Annual Best Ideas Conference 2018 on Thursday, September 13, 2018.

PDL BioPharma, Inc. announces that John McLaughlin, PDL’s chief executive officer, will present at the H.C. Wainwright 20th Annual Global Investment Conference.

Research collaboration aims to uncover new insights into ovarian biology and accelerate the development of personalized interventions in reproductive medicine and women’s health.

Eureka Therapeutics, Inc.,today announced that new proof-of-concept preliminary data from its ongoing China clinical study evaluating ET140202 for the treatment of AFP-positive hepatocellular carcinoma (AFP+ HCC) will be presented as a late-breaking oral presentation at the 4th Annual CAR-TCR Summit in Boston,

Shionogi & Co., Ltd. announced today that Mulpleta® is now available throughout the United States.

Starkey® Hearing Technologies has reinvented both the hearing experience and the hearing aid with Livio AI. Livio AI is the world’s first Healthable™ hearing aid to utilize integrated sensors and artificial intelligence, and the first to track physical activity and cognitive health.

Pfizer Inc.. (NYSE: PFE) announced today that it is terminating two ongoing clinical studies evaluating domagrozumab (PF-06252616) for the treatment of Duchenne muscular dystrophy (DMD): a Phase 2 safety and efficacy study (B5161002) and an open-label extension study (B5161004).

Veracyte, Inc. (Nasdaq: VCYT) today announced that Bonnie H. Anderson, chairman and chief executive officer, will present at the Morgan Stanley 16th Annual Global Healthcare Conference on Thursday, September 13, 2018 at 2:55 p.m. Eastern Time in New York City.

BlueWind Medical, developer of the RENOVA iStim(TM), an innovative, leadless, miniature, wireless neurostimulation platform, for the treatment of multiple clinical indications, announced today the publication of long-term clinical results of OPTIMIST follow-up study.